JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.21B |
| 2 |
Microsoft
MSFT
|
+$2.18B |
| 3 |
Tesla
TSLA
|
+$1.1B |
| 4 |
NXP Semiconductors
NXPI
|
+$1.04B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$998M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$4.32B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.5B |
| 4 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.31B |
| 5 |
PayPal
PYPL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.77% |
| 2 | Financials | 10.48% |
| 3 | Healthcare | 9.83% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Titan International
TWI
$440M
| $5M | ﹤0.01% |
456,511
+408,373
| +848% | +$3.2M |
|
2952
IPG Photonics
IPGP
$3.63B
| $4.99M | ﹤0.01% |
28,997
-14,436
| -33% | -$2.38M |
|
|
GBT
2953
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.99M | ﹤0.01% |
170,456
+117,734
| +223% | +$3.65M |
|
|
EAR
2954
DELISTED
Eargo, Inc. Common Stock
EAR
| $4.99M | ﹤0.01% |
48,917
+17,904
| +58% | +$2.33M |
|
|
CMRC
2955
Commerce.com Inc Series 1
CMRC
$185M
| $4.98M | ﹤0.01% |
140,680
-28,999
| -17% | -$1.36M |
|
2956
Virtu Financial
VIRT
$5.13B
| $4.97M | ﹤0.01% |
172,334
-18,924
| -10% | -$516K |
|
|
FFIC
2957
DELISTED
Flushing Financial
FFIC
| $4.97M | ﹤0.01% |
204,401
+25,067
| +14% | +$599K |
|
2958
John B. Sanfilippo & Son
JBSS
$1.01B
| $4.96M | ﹤0.01% |
55,036
+9,214
| +20% | +$789K |
|
|
WBA
2959
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $4.96M | ﹤0.01% |
95,100
| – | – |
|
|
PARAP
2960
DELISTED
Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock
PARAP
| $4.96M | ﹤0.01% |
+98,755
| New | +$5.69M |
|
2961
TG Therapeutics
TGTX
$7.43B
| $4.94M | ﹤0.01% |
260,111
+99,635
| +62% | +$2.59M |
|
2962
Celldex Therapeutics
CLDX
$3.26B
| $4.94M | ﹤0.01% |
127,834
-83,619
| -40% | -$3.64M |
|
|
SPAQ
2963
DELISTED
Spartan Acquisition Corp. III
SPAQ
| $4.93M | ﹤0.01% |
+500,000
| New | +$4.96M |
|
|
UBA
2964
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $4.93M | ﹤0.01% |
231,659
+6,895
| +3% | +$138K |
|
2965
Costamare
CMRE
$1.76B
| $4.93M | ﹤0.01% |
389,688
-423,194
| -52% | -$5.54M |
|
2966
Intercorp Financial Services
IFS
$6.04B
| $4.92M | ﹤0.01% |
186,576
-197,382
| -51% | -$5.04M |
|
2967
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.73B
| $4.92M | ﹤0.01% |
132,925
-252,575
| -66% | -$9.38M |
|
2968
PUT
3M
MMM
$94.8B
| $4.92M | ﹤0.01% |
33,129
+239
| +0.7% | +$35.6K |
|
2969
Vanguard Extended Market ETF
VXF
$32.3B
| $4.92M | ﹤0.01% |
26,904
+381
| +1% | +$71.6K |
|
2970
Teva Pharmaceuticals
TEVA
$42.6B
| $4.92M | ﹤0.01% |
613,796
+23,384
| +4% | +$211K |
|
2971
Treace Medical Concepts
TMCI
$308M
| $4.91M | ﹤0.01% |
263,507
+176,598
| +203% | +$3.64M |
|
|
NBIS
2972
PUT
Nebius Group N.V.
NBIS
$74.8B
| $4.91M | ﹤0.01% |
+81,100
| New | +$5.97M |
|
|
VYGG
2973
DELISTED
Vy Global Growth
VYGG
| $4.91M | ﹤0.01% |
500,000
| – | – |
|
2974
PUT
Huazhu Hotels Group
HTHT
$12.8B
| $4.88M | ﹤0.01% |
+130,700
| New | +$5.71M |
|
2975
PUT
TSMC
TSM
$2.21T
| $4.86M | ﹤0.01% |
40,400
-194,100
| -83% | -$22.7M |
|
Similar funds
JP Morgan Chase's Q4 2021 Portfolio in Review
As of Q4 2021, JP Morgan Chase held 7,322 positions worth $866B, up 7.1% from $809B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2021 filing shows 665 new, 2,967 increased, 2,175 reduced and 543 closed positions. Its largest new stake was Rivian: 4,642,731 shares worth $481M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $4.32B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2021 buy was Rivian: 4,642,731 shares worth $481M.
- JP Morgan Chase added most to Amazon in Q4 2021, an estimated $2.21B increase.
- JP Morgan Chase's biggest Q4 2021 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $4.32B.
- JP Morgan Chase fully exited Kansas City Southern in Q4 2021, selling an estimated $499M.
- JP Morgan Chase's ten largest holdings make up 17% of its $866B portfolio in Q4 2021.
- JP Morgan Chase opened 665 new positions and closed 543 in Q4 2021.
- JP Morgan Chase's portfolio value rose 7.1% quarter-over-quarter to $866B.
Based on JP Morgan Chase's 13F filing for Q4 2021, filed 10 Feb 2022.